BFLY

Butterfly Network, Inc.

61
Fundamentals67/ 100
Valuation50/ 100
Upside potential66/ 100
Risk potential47/ 100

BFLY offers stronger modeled upside, but that advantage does not outweigh its weaker overall profile.

OSCR

Oscar Health, Inc.

69
Fundamentals85/ 100
Valuation50/ 100
Upside potential61/ 100
Risk potential35/ 100

OSCR has the edge over BFLY overall, supported by stronger fundamentals and lower modeled downside.

BFLY Fundamentals

MetricStatus
Strong
Under pressure
Weak
Unavailable

BFLY's revenue is currently strong, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.

OSCR Fundamentals

MetricStatus
Strong
Healthy
Strong
Strong

OSCR's revenue, profitability, cash flow and balance sheet are all currently healthy.

BFLY PE Valuation

BFLY has no meaningful PE right now: it lost money over the past year.

OSCR PE Valuation

CHEAPFAIREXPENSIVE41x83x124x166x
CHEAPFAIREXPENSIVE41x83x124x166x
LevelPEPriceVs current
Forward12x$31.94—
Current13x$31.94—
Cheap21x$52.73+65%
Fair35x$87.23+173%
Expensive130x$322+907%

Historical ranges are pointers, not guarantees.

OSCR's PE is 13x, but its earnings don't support one, so it isn't a reliable read right now.

BFLY Forward outlook

MetricOutlook
--
Losses shrinking
Strong growth
Strongly improving
Limited
High

Analysts expect BFLY's losses to shrink, with revenue growing.

OSCR Forward outlook

MetricOutlook
Improving
Strong growth
Strong growth
Strongly improving
Limited
Moderate

Analysts expect strong earnings and revenue growth for OSCR, with profitability improving.

BFLY Risk to reward

ScenarioChangePrice
Upside+91%$12.75
Downside-47%$3.51

Calculated from the latest close: $6.67 on Nov 12.

BFLY has a better modeled risk to reward balance than OSCR, with more potential upside relative to its potential downside.

OSCR Risk to reward

ScenarioChangePrice
Upside+55%$49.45
Downside-35%$20.78

Calculated from the latest close: $31.94 on Nov 12.

OSCR trails BFLY on modeled risk to reward, with less potential upside relative to its potential downside.

BFLY Earnings Per Share

Q4 2023: $-0.65Q1 2024: $-0.58Q2 2024: $-0.51Q3 2024: $-0.46Q4 2024: $-0.34Q1 2025: $-0.30Q2 2025: $-0.29Q3 2025: $-0.34Q4 2025: $-0.31Q1 2026: $-0.30Q2 2026: $-0.29Q3 2026: $-0.21
Q4 2023: $-0.65Q1 2024: $-0.58Q2 2024: $-0.51Q3 2024: $-0.46Q4 2024: $-0.34Q1 2025: $-0.30Q2 2025: $-0.29Q3 2025: $-0.34Q4 2025: $-0.31Q1 2026: $-0.30Q2 2026: $-0.29Q3 2026: $-0.21
QuarterTTM EPSYoY
Q3 2026-$0.21+$0.13
Q2 2026-$0.29$0.00
Q1 2026-$0.30$0.00
Q4 2025-$0.31+$0.03
Q3 2025-$0.34+$0.12
Q2 2025-$0.29+$0.22
Q1 2025-$0.30+$0.28
Q4 2024-$0.34+$0.31

BFLY is still losing money, but far less than before: $0.21 per share over the past year, against $0.84 at its worst in late 2022.

OSCR Earnings Per Share

Q4 2023: $-1.22Q1 2024: $-0.42Q2 2024: $-0.15Q3 2024: $-0.08Q4 2024: $0.10Q1 2025: $0.40Q2 2025: $-0.69Q3 2025: $-1.00Q4 2025: $-1.69Q1 2026: $-0.54Q2 2026: $1.45Q3 2026: $2.47Forward: $2.61
Q4 2023: $-1.22Q1 2024: $-0.42Q2 2024: $-0.15Q3 2024: $-0.08Q4 2024: $0.10Q1 2025: $0.40Q2 2025: $-0.69Q3 2025: $-1.00Q4 2025: $-1.69Q1 2026: $-0.54Q2 2026: $1.45Q3 2026: $2.47Forward: $2.61
QuarterTTM EPSYoY
Forward$2.61+5.6%
Q3 2026$2.47+$3.47
Q2 2026$1.45+$2.14
Q1 2026-$0.54-235%
Q4 2025-$1.69-1790%
Q3 2025-$1.00-$0.92
Q2 2025-$0.69-$0.54
Q1 2025$0.40+$0.82
Q4 2024$0.10+$1.32

OSCR has the edge over BFLY on earnings quality, reporting a profit while its opponent remains loss making.

BFLY Quarterly Revenue

Q4 2023: $17MQ1 2024: $18MQ2 2024: $21MQ3 2024: $21MQ4 2024: $22MQ1 2025: $21MQ2 2025: $23MQ3 2025: $21MQ4 2025: $32MQ1 2026: $27MQ2 2026: $33MQ3 2026: $33M
Q4 2023: $17MQ1 2024: $18MQ2 2024: $21MQ3 2024: $21MQ4 2024: $22MQ1 2025: $21MQ2 2025: $23MQ3 2025: $21MQ4 2025: $32MQ1 2026: $27MQ2 2026: $33MQ3 2026: $33M
QuarterRevenueYoY
Q3 2026$32.6M+52%
Q2 2026$32.6M+39%
Q1 2026$26.5M+25%
Q4 2025$31.5M+41%
Q3 2025$21.5M+4.5%
Q2 2025$23.4M+8.8%
Q1 2025$21.2M+20%
Q4 2024$22.4M+35%

BFLY's revenue has grown year over year for 11 quarters in a row: $33M last quarter, up 52% from the same quarter a year ago.

OSCR Quarterly Revenue

Q4 2023: $1.4BQ1 2024: $2.1BQ2 2024: $2.2BQ3 2024: $2.4BQ4 2024: $2.4BQ1 2025: $3BQ2 2025: $2.9BQ3 2025: $3BQ4 2025: $2.8BQ1 2026: $4.6BQ2 2026: $4.9BQ3 2026: $5.1B
Q4 2023: $1.4BQ1 2024: $2.1BQ2 2024: $2.2BQ3 2024: $2.4BQ4 2024: $2.4BQ1 2025: $3BQ2 2025: $2.9BQ3 2025: $3BQ4 2025: $2.8BQ1 2026: $4.6BQ2 2026: $4.9BQ3 2026: $5.1B
QuarterRevenueYoY
Q3 2026$5.1B+72%
Q2 2026$4.9B+70%
Q1 2026$4.6B+53%
Q4 2025$2.8B+17%
Q3 2025$3B+23%
Q2 2025$2.9B+29%
Q1 2025$3B+42%
Q4 2024$2.4B+67%

OSCR has the edge over BFLY on sales, with stronger typical year-over-year growth.

BFLY Free Cash Flow

Q4 2023: −$16MQ1 2024: −$22MQ2 2024: −$11MQ3 2024: −$8MQ4 2024: −$4MQ1 2025: −$12MQ2 2025: −$8MQ3 2025: −$4MQ4 2025: $8MQ1 2026: −$15MQ2 2026: −$17MQ3 2026: −$3M
Q4 2023: −$16MQ1 2024: −$22MQ2 2024: −$11MQ3 2024: −$8MQ4 2024: −$4MQ1 2025: −$12MQ2 2025: −$8MQ3 2025: −$4MQ4 2025: $8MQ1 2026: −$15MQ2 2026: −$17MQ3 2026: −$3M
QuarterFree cash flowYoY
Q3 2026-$3.4M+$492K
Q2 2026-$17.2M-$9.2M
Q1 2026-$14.8M-$2.8M
Q4 2025$7.9M+$11.5M
Q3 2025-$3.9M+$4.4M
Q2 2025-$8.1M+$2.7M
Q1 2025-$12M+$9.8M
Q4 2024-$3.5M+$12.1M

BFLY has burned cash in almost every quarter: −$28M over the past year, against −$28M the year before.

OSCR Free Cash Flow

Q4 2023: $291MQ1 2024: $628MQ2 2024: $490MQ3 2024: −$508MQ4 2024: $340MQ1 2025: $870MQ2 2025: $500MQ3 2025: −$974MQ4 2025: $663MQ1 2026: $2.6BQ2 2026: $2.1BQ3 2026: −$1.2B
Q4 2023: $291MQ1 2024: $628MQ2 2024: $490MQ3 2024: −$508MQ4 2024: $340MQ1 2025: $870MQ2 2025: $500MQ3 2025: −$974MQ4 2025: $663MQ1 2026: $2.6BQ2 2026: $2.1BQ3 2026: −$1.2B
QuarterFree cash flowYoY
Q3 2026-$1.2B-$238.2M
Q2 2026$2.1B+316%
Q1 2026$2.6B+200%
Q4 2025$662.8M+95%
Q3 2025-$973.7M-$466M
Q2 2025$499.8M+2.1%
Q1 2025$869.5M+38%
Q4 2024$340M+17%

OSCR has the edge over BFLY on cash generation, producing positive trailing cash flow while its opponent burns cash.

BFLY Total Shares

Q4 2023: 205MQ1 2024: 209MQ2 2024: 212MQ3 2024: 213MQ4 2024: 212MQ1 2025: 235MQ2 2025: 248MQ3 2025: 252MQ4 2025: 247MQ1 2026: 257MQ2 2026: 262MQ3 2026: 266M
Q4 2023: 205MQ1 2024: 209MQ2 2024: 212MQ3 2024: 213MQ4 2024: 212MQ1 2025: 235MQ2 2025: 248MQ3 2025: 252MQ4 2025: 247MQ1 2026: 257MQ2 2026: 262MQ3 2026: 266M
PeriodChange %Net change
Quarterly+1.7%+4.4M shares
1 year+5.7%+14.4M shares
3 years+29%+59.8M shares
5 years+36%+70.4M shares

BFLY has the edge over OSCR on shareholder dilution, with a more favorable share count trend.

OSCR Total Shares

Q4 2023: 222MQ1 2024: 294MQ2 2024: 304MQ3 2024: 243MQ4 2024: 266MQ1 2025: 306MQ2 2025: 256MQ3 2025: 259MQ4 2025: 262MQ1 2026: 330MQ2 2026: 333MQ3 2026: 346M
Q4 2023: 222MQ1 2024: 294MQ2 2024: 304MQ3 2024: 243MQ4 2024: 266MQ1 2025: 306MQ2 2025: 256MQ3 2025: 259MQ4 2025: 262MQ1 2026: 330MQ2 2026: 333MQ3 2026: 346M
PeriodChange %Net change
Quarterly+3.9%+13M shares
1 year+34%+87.2M shares
3 years+55%+123M shares
5 years+66%+138M shares
Available history+71%+143M shares

OSCR has 346M diluted shares, up 34% from a year ago.

BFLY Net Leverage

BFLY's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.

OSCR Net Leverage

Q1 2024: -217.7xQ2 2024: -24.0xQ3 2024: -10.1xQ4 2024: -13.7xQ1 2025: -9.7xQ1 2026: -110.0xQ2 2026: -5.5xQ3 2026: -4.2x
Q1 2024: -217.7xQ2 2024: -24.0xQ3 2024: -10.1xQ4 2024: -13.7xQ1 2025: -9.7xQ1 2026: -110.0xQ2 2026: -5.5xQ3 2026: -4.2x
QuarterNet LeverageStatus
Q3 2026-4.2xNet Cash
Q2 2026-5.5xNet Cash
Q1 2026-110.0xNet Cash
Q1 2025-9.7xNet Cash
Q4 2024-13.7xNet Cash
Q3 2024-10.1xNet Cash
Q2 2024-24.0xNet Cash
Q1 2024-217.7xNet Cash

OSCR has more cash than debt.

BFLY Weekly Momentum

MetricValueStatus
RSI48.3Neutral
Stochastic11.0Oversold

BFLY's weekly RSI is 48 (neutral) and its Stochastic is 11 (oversold).

OSCR Weekly Momentum

MetricValueStatus
RSI58.7Neutral
Stochastic44.9Neutral

OSCR's weekly RSI is 59 (neutral) and its Stochastic is 45 (neutral).

BFLY PE vs Healthcare Sector

BFLY has no meaningful PE right now: it lost money over the past year.

OSCR PE vs Healthcare Sector

MetricOSCRSector medianRelative
PE13x26x50% below
PE %33532 pts below

OSCR is trading at 13x earnings, a 50% discount to the Healthcare sector's median of 26x, though its earnings don't support one.

BFLY Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$7.5011% below
20 week MA$7.7113% below
50 week MA$5.7217% above
100 week MA$4.1262% above
200 week MA$2.87132% above

BFLY has pulled back, but its long-term trend is still up: it's below its 8- and 20-week averages, but 132% above its 200-week average.

OSCR Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$31.22.3% above
20 week MA$31.12.8% above
50 week MA$22.939% above
100 week MA$19.365% above
200 week MA$15.5106% above

OSCR has the edge over BFLY on trend strength, trading above more of its moving averages.

BFLY Yearly ROI

YearStart priceEnd priceROI
2020$10.1$21.1+108%
2021$21.1$7.39-65%
2022$7.39$2.36-68%
2023$2.36$1.08-54%
2024$1.08$3.46+220%
2025$3.46$3.85+11%
2026 YTD$3.85$6.67+73%

BFLY's yearly returns have swung widely, from +220% in 2024 to −68% in 2022. It's up 73% so far in 2026.

OSCR Yearly ROI

YearStart priceEnd priceROI
2021$31.0$8.02-74%
2022$8.02$2.21-72%
2023$2.21$9.15+314%
2024$9.15$13.8+51%
2025$13.8$14.9+8%
2026 YTD$14.9$31.9+114%

OSCR has the edge over BFLY on returns for 2026, with the stronger performance.

Give your agent the market.

Get API key